Dashboard
Manage Tickers

BCYPBLUE CALYPSO, INC.

www.bluecalypso.com


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.0065
-- x --
-- x --
-- - --
$ 0.01 - $ 0.05
1,000
na
51,168
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2016 09-30-2016 10-Q
2 08-10-2016 06-30-2016 10-Q
3 05-16-2016 03-31-2016 10-Q
4 03-22-2016 12-31-2015 10-K
5 11-16-2015 09-30-2015 10-Q
6 08-03-2015 06-30-2015 10-Q
7 05-14-2015 03-31-2015 10-Q
8 03-17-2015 12-31-2014 10-K
9 11-12-2014 09-30-2014 10-Q
10 08-13-2014 06-30-2014 10-Q
11 05-09-2014 03-31-2014 10-Q
12 03-31-2014 12-31-2013 10-K
13 11-08-2013 09-30-2013 10-Q
14 08-29-2013 06-30-2013 10-Q
15 05-15-2013 03-31-2013 10-Q
16 03-29-2013 12-31-2012 10-K
17 11-19-2012 09-30-2012 10-Q
18 08-15-2012 06-30-2012 10-Q
19 05-15-2012 03-31-2012 10-Q
20 04-16-2012 12-31-2011 10-K
21 11-14-2011 09-30-2011 10-Q
22 08-18-2011 06-30-2011 10-Q
23 05-11-2011 03-31-2011 10-Q
24 03-21-2011 12-31-2010 10-K
25 11-05-2010 09-30-2010 10-Q
26 07-28-2010 06-30-2010 10-Q
27 05-17-2010 03-31-2010 10-Q
28 03-16-2010 12-31-2009 10-K
29 11-13-2009 09-30-2009 10-Q
30 08-13-2009 06-30-2009 10-Q
31 05-14-2009 03-31-2009 10-Q
32 03-05-2009 12-31-2008 10-K
33 11-10-2008 09-30-2008 10-Q
34 08-13-2008 06-30-2008 10-Q
35 05-12-2008 03-31-2008 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

55-biggest-movers-from-friday
55 Biggest Movers From Friday
10/25/2021 09:28:32

Gainers

big-cypress-acquisition-corp-stockholders-approve-business-combination-with-sab-biotherapeutics
Big Cypress Acquisition Corp. Stockholders...
10/21/2021 11:21:03

october-spac-merger-calendar-a-look-at-upcoming-votes-stocks-to-watch
October SPAC Merger Calendar: A Look At Up...
10/04/2021 16:13:29

The month of October marks a slowdown in SPAC merger deal votes, but the calendar does include several multibillion-dollar deal...

northland-capital-markets-initiates-coverage-on-big-cypress-acquisition-with-outperform-rating-announces-price-target-of-18
Northland Capital Markets Initiates Covera...
10/04/2021 14:24:53

Northland Capital Markets analyst Tim Chiang initiates coverage on Big Cypress Acquisition (NASDAQ:BCYP) with a Outperform r...

big-cypress-acquisition-merger-partner-sab-biotherapeutics-announces-first-patient-dosed-in-phase-3-nih-activ-2-trial-evaluating-sab-185-for-treatment-of-covid-19
Big Cypress Acquisition Merger Partner SAB...
10/04/2021 11:03:35

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...

benzingas-top-ratings-upgrades-downgrades-for-october-1-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/01/2021 14:02:57

 

ladenburg-thalmann-initiates-coverage-on-big-cypress-acquisition-with-buy-rating-announces-price-target-of-165
Ladenburg Thalmann Initiates Coverage On B...
10/01/2021 11:01:33

Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Big Cypress Acquisition (NASDAQ:BCYP) with a Buy rating and a...

big-cypress-acquisition-corp-merger-partner-sab-biotherapeutics-announces-independent-data-safety-monitoring-board-has-completed-interim-analysis-of-sab-185-in-phase-2-portion-of-activ-2-trial-and-recommended-advancement-to-phase-3
Big Cypress Acquisition Corp. Merger Partn...
09/24/2021 11:02:55

sab-biotherapeutics-awarded-additional-605m-from-barda-and-us-department-of-defense-for-rapid-response-capability-and-advancing-sab-185-for-treatment-of-covid-19
SAB Biotherapeutics Awarded Additional $60...
09/22/2021 11:02:30

  $200 million total awarded to date for DiversitAb™ Rapid Response Antibody Program including Stage 4 COVID-19 Pandemic Respo...

big-cypress-acquisition-merger-partner-sab-biotherapeutics-announces-completion-of-enrollment-in-phase-2a-challenge-trial-of-sab-176-for-the-treatment-of-seasonal-influenza
Big Cypress Acquisition Merger Partner SAB...
09/15/2021 11:01:19

big-cypress-acquisition-corp-spac-merger-partner-sab-biotherapeutics-gives-non-clinical-data-showing-sab-185-potently-neutralizes-deal-lambda-sars-cov-2-variants
Big Cypress Acquisition Corp. SPAC Merger ...
08/11/2021 11:17:15

correction-big-cypress-spac-merger-partner-sab-issued-preclinical-data-on-its-sab-185-this-morning-at-706-am-edt
CORRECTION: Big Cypress SPAC Merger Partne...
07/08/2021 21:16:51

big-cypress-acquisition-corp-spac-merger-partner-sab-biotherapeutics-highlights-publication-of-preclinical-data-showing-sab-185-effectively-neutralizes-sars-cov-2-variants
Big Cypress Acquisition Corp. SPAC Merger ...
07/08/2021 21:14:07

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...

big-cypress-acquisition-corp-spac-merger-partner-sab-biotherapeutics-highlights-publication-of-preclinical-data-demonstrating-sab-185-effectively-neutralizes-sars-cov-2-variants
Big Cypress Acquisition Corp. SPAC Merger ...
07/08/2021 11:08:38

Findings Published in Human Vaccines & Immunotherapeutics Show SAB-185 Neutralizes Virus Strains Containing Substitutions P...

big-cypress-acquisition-corp-announces-confidential-submission-of-s-4-registration-statement-related-to-proposed-business-combination-with-sab-biotherapeutics
Big Cypress Acquisition Corp. Announces Co...
07/07/2021 11:05:25

big-cypress-acquisition-merger-partner-sab-biotherapeutics-reports-dosing-of-first-patient-in-phase-2a-trial-of-sab-176-for-treatment-of-flu
Big Cypress Acquisition Merger Partner, SA...
07/02/2021 11:49:28

sab-biotherapeutics-doses-first-participant-in-phase-2a-trial-of-sab-176-for-the-treatment-of-influenza
SAB Biotherapeutics Doses First Participan...
06/29/2021 11:15:32

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...

sab-biotherapeutics-to-go-public-through-merger-with-big-cypress-acquisition-corp-transaction-implies-enterprise-value-of-325m
SAB Biotherapeutics To Go Public Through M...
06/22/2021 10:03:19

SAB Biotherapeutics (SAB) has entered into a definitive merger agreement with Big Cypress Acquisition Corp. (NASDAQ:BCYP) and...

Core News & Articles
Stocks Making New 52-Week Highs/Lows For W...
02/10/2021 19:30:53

52-Week Highs: BeiGene (BGNE) Plus Therapeutics (PSTV) Bilibili (BILI) Whiting Petroleum (WLL) Yiren Digital (YRD) Cara...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)